We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBOW
2426
DELISTED
SilverBow Resources, Inc.
SBOW
| $725K | ﹤0.01% |
24,889
+5,291
| +27% | +$131K |
|
2427
Nuvation Bio
NUVB
$2.32B
| $720K | ﹤0.01% |
400,209
+228,478
| +133% | +$388K |
|
2428
Dyne Therapeutics
DYN
$4.9B
| $719K | ﹤0.01% |
63,912
+12,732
| +25% | +$150K |
|
2429
Phathom Pharmaceuticals
PHAT
$692M
| $719K | ﹤0.01% |
50,205
+17,444
| +53% | +$201K |
|
2430
Peapack-Gladstone Financial
PGC
$812M
| $719K | ﹤0.01% |
26,537
-883
| -3% | -$24.1K |
|
2431
Allogene Therapeutics
ALLO
$694M
| $717K | ﹤0.01% |
144,241
+15,009
| +12% | +$81.2K |
|
2432
Future Fuel
FF
$223M
| $712K | ﹤0.01% |
80,467
-2,025
| -2% | -$16.9K |
|
2433
Genesco
GCO
$422M
| $712K | ﹤0.01% |
28,415
-14,581
| -34% | -$422K |
|
2434
Boston Omaha
BOC
$436M
| $711K | ﹤0.01% |
37,793
+3,377
| +10% | +$68.6K |
|
2435
Enliven Therapeutics
ELVN
$4.43B
| $710K | ﹤0.01% |
+34,796
| New | +$703K |
|
2436
Franklin Covey
FC
$246M
| $708K | ﹤0.01% |
16,214
+229
| +1% | +$8.48K |
|
2437
Grid Dynamics Holdings
GDYN
$615M
| $707K | ﹤0.01% |
76,406
+1,797
| +2% | +$18K |
|
|
WOW
2438
DELISTED
WideOpenWest
WOW
| $706K | ﹤0.01% |
83,629
+5,720
| +7% | +$51.7K |
|
2439
Definitive Healthcare
DH
$75.3M
| $705K | ﹤0.01% |
64,114
+31,328
| +96% | +$323K |
|
2440
MasterCraft Boat Holdings
MCFT
$590M
| $704K | ﹤0.01% |
22,969
-1,484
| -6% | -$42.8K |
|
2441
i3 Verticals
IIIV
$342M
| $702K | ﹤0.01% |
30,723
+403
| +1% | +$9.39K |
|
2442
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $701K | ﹤0.01% |
17,142
+2,970
| +21% | +$115K |
|
2443
Carter Bankshares
CARE
$731M
| $701K | ﹤0.01% |
47,406
+9,641
| +26% | +$136K |
|
2444
Alignment Healthcare
ALHC
$2.98B
| $700K | ﹤0.01% |
121,825
-6,536
| -5% | -$42.3K |
|
2445
Amplify Energy
AMPY
$166M
| $699K | ﹤0.01% |
103,242
+29,323
| +40% | +$204K |
|
2446
Tencent Music
TME
$15.6B
| $699K | ﹤0.01% |
+94,677
| New | +$715K |
|
|
CFB
2447
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $694K | ﹤0.01% |
69,441
-759
| -1% | -$7.83K |
|
2448
Teekay
TK
$985M
| $693K | ﹤0.01% |
114,795
+1,556
| +1% | +$9.08K |
|
2449
Vera Therapeutics
VERA
$2.36B
| $693K | ﹤0.01% |
43,151
+15,857
| +58% | +$143K |
|
2450
ENI
E
$77.5B
| $692K | ﹤0.01% |
+24,046
| New | +$697K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.